Net Income (Loss) Attributable to Parent in USD of Twist Bioscience Corp from 2017 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Twist Bioscience Corp quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from 2017 to Q3 2025.
  • Twist Bioscience Corp Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was -$27.1M, a 21.7% increase year-over-year.
  • Twist Bioscience Corp Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was -$77.7M, a 62.8% increase year-over-year.
  • Twist Bioscience Corp annual Net Income (Loss) Attributable to Parent for 2025 was -$77.7M, a 62.8% increase from 2024.
  • Twist Bioscience Corp annual Net Income (Loss) Attributable to Parent for 2024 was -$209M, a 2.01% decline from 2023.
  • Twist Bioscience Corp annual Net Income (Loss) Attributable to Parent for 2023 was -$205M, a 6.08% increase from 2022.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

Twist Bioscience Corp Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$77.7M -$27.1M +$7.52M +21.7% 01 Jul 2025 30 Sep 2025 10-K 17 Nov 2025
Q2 2025 -$85.2M $20.4M +$106M 01 Apr 2025 30 Jun 2025 10-Q 04 Aug 2025
Q1 2025 -$191M -$39.3M +$6.16M +13.6% 01 Jan 2025 31 Mar 2025 10-Q 05 May 2025
Q4 2024 -$197M -$31.6M +$11.4M +26.5% 01 Oct 2024 31 Dec 2024 10-Q 03 Feb 2025
Q3 2024 -$209M -$34.7M +$11.6M +25.1% 01 Jul 2024 30 Sep 2024 10-K 17 Nov 2025
Q2 2024 -$220M -$85.6M -$28.2M -49.1% 01 Apr 2024 30 Jun 2024 10-Q 04 Aug 2025
Q1 2024 -$192M -$45.5M +$13.7M +23.1% 01 Jan 2024 31 Mar 2024 10-Q 05 May 2025
Q4 2023 -$206M -$43M -$1.18M -2.83% 01 Oct 2023 31 Dec 2023 10-Q 03 Feb 2025
Q3 2023 -$205M -$46.2M +$4.87M +9.53% 01 Jul 2023 30 Sep 2023 10-K 17 Nov 2025
Q2 2023 -$209M -$57.4M +$3.12M +5.16% 01 Apr 2023 30 Jun 2023 10-Q 02 Aug 2024
Q1 2023 -$213M -$59.2M +$1.51M +2.49% 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024
Q4 2022 -$214M -$41.8M +$3.74M +8.21% 01 Oct 2022 31 Dec 2022 10-Q 02 Feb 2024
Q3 2022 -$218M -$51.1M -$9.87M -23.9% 01 Jul 2022 30 Sep 2022 10-K 18 Nov 2024
Q2 2022 -$208M -$60.5M -$20.5M -51.2% 01 Apr 2022 30 Jun 2022 10-Q 07 Aug 2023
Q1 2022 -$188M -$60.7M -$22.7M -60% 01 Jan 2022 31 Mar 2022 10-Q 08 May 2023
Q4 2021 -$165M -$45.6M -$12.7M -38.5% 01 Oct 2021 31 Dec 2021 10-Q 07 Feb 2023
Q3 2021 -$152M -$41.2M -$16.9M -69.6% 01 Jul 2021 30 Sep 2021 10-K 21 Nov 2023
Q2 2021 -$135M -$40M -$11.8M -41.9% 01 Apr 2021 30 Jun 2021 10-Q 08 Aug 2022
Q1 2021 -$123M -$37.9M -$6.15M -19.4% 01 Jan 2021 31 Mar 2021 10-Q 06 May 2022
Q4 2020 -$117M -$32.9M +$22.7M +40.9% 01 Oct 2020 31 Dec 2020 10-Q 09 Feb 2022
Q3 2020 -$140M -$24.3M +$6.86M +22% 01 Jul 2020 30 Sep 2020 10-K/A 05 Jun 2023
Q2 2020 -$147M -$28.2M -$291K -1.04% 01 Apr 2020 30 Jun 2020 10-Q 09 Aug 2021
Q1 2020 -$147M -$31.8M -$5.84M -22.5% 01 Jan 2020 31 Mar 2020 10-Q 07 May 2021
Q4 2019 -$141M -$55.6M -$33M -146% 01 Oct 2019 31 Dec 2019 10-Q 09 Feb 2021
Q3 2019 -$108M -$31.2M -$11.4M -57.5% 01 Jul 2019 30 Sep 2019 10-K 23 Nov 2021
Q2 2019 -$96.3M -$27.9M -$10.3M -58.4% 01 Apr 2019 30 Jun 2019 10-Q 12 Aug 2020
Q1 2019 -$86M -$25.9M -$9.06M -53.7% 01 Jan 2019 31 Mar 2019 10-Q 13 May 2020
Q4 2018 -$76.9M -$22.6M -$5.7M -33.7% 01 Oct 2018 31 Dec 2018 10-Q 10 Feb 2020
Q3 2018 -$71.2M -$19.8M 01 Jul 2018 30 Sep 2018 10-K 27 Nov 2020
Q2 2018 -$17.6M 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2019
Q1 2018 -$16.9M 01 Jan 2018 31 Mar 2018 10-Q 02 May 2019
Q4 2017 -$16.9M 01 Oct 2017 31 Dec 2017 10-Q 11 Feb 2019

Twist Bioscience Corp Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2025 -$77.7M +$131M +62.8% 01 Oct 2024 30 Sep 2025 10-K 17 Nov 2025
2024 -$209M -$4.11M -2.01% 01 Oct 2023 30 Sep 2024 10-K 17 Nov 2025
2023 -$205M +$13.2M +6.08% 01 Oct 2022 30 Sep 2023 10-K 17 Nov 2025
2022 -$218M -$65.8M -43.2% 01 Oct 2021 30 Sep 2022 10-K 18 Nov 2024
2021 -$152M -$12.2M -8.7% 01 Oct 2020 30 Sep 2021 10-K 21 Nov 2023
2020 -$140M -$32.3M -30% 01 Oct 2019 30 Sep 2020 10-K/A 05 Jun 2023
2019 -$108M -$36.4M -51.1% 01 Oct 2018 30 Sep 2019 10-K 23 Nov 2021
2018 -$71.2M -$11.9M -20.1% 01 Oct 2017 30 Sep 2018 10-K 27 Nov 2020
2017 -$59.3M 01 Oct 2016 30 Sep 2017 10-K 13 Dec 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.